| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |